OmegAvail Hi-Po
Natural health product licensed in Canada
- Other names
- Aumega, Hi Potency Omega 3'S
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80082039
- Status
- Active licence
- Licence date
- 27 December 2017
- Revision date
- 13 January 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Engraulidae - en entier Potency : 500 milligramme Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 250 milligramme Docosahexaenoic acid | 1,000 milligramme | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 500 milligramme Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 250 milligramme Docosahexaenoic acid | 1,000 milligramme | Not calculated |
| Triacylglycérol lipase Source : Aspergillus flavus var. oryzae - En entier | 0.125 milligramme | Not calculated |
| Triacylglycérol lipase Source : Aspergillus flavus var. oryzae - En entier | 275 FCC LU | Not calculated |
Non-medicinal ingredients
Gélatine, Saveur de citron, tocotriénols, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Source of omega-3 fatty acids for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use.
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80082039
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging